Avalon Ventures Email Format
Venture Capital and Private Equity PrincipalsUnited States11-50 Employees
Avalon Ventures is a United States-based venture capital firm with a 30-year history of supporting seed and early-stage ventures in information technology and life sciences. Its partners are seasoned entrepreneurs who contribute to company formation, operations, and value creation, engaging with portfolio companies across team building, strategy, and early development. The firm has founded or funded more than 100 IT and life sciences ventures. Notable activity includes a 2019 announcement that Avalon Ventures had entered into a definitive agreement with GlaxoSmithKline for the acquisition of Sitari Pharmaceuticals. The firm emphasizes close collaboration with its portfolio companies, reflecting its long tenure in the life sciences and tech sectors. Based in the United States, Avalon maintains a focus on seed and early-stage opportunities across technology and biotech through its network of experienced entrepreneurs.